Savara logo

Savara share price today

(SVRA)

Savara share price is $3.2 & ₹272.63 as on 25 Dec 2024, 2.30 'hrs' IST

$3.2

-0.05

(-1.54%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Savara share price in Dollar and Rupees. Guide to invest in Savara from India. Also see the sentimental analysis on Indian investors investing in Savara. Get details on the Indian mutual funds that are investing in Savara. Get Analyst recommendations and forecasts along with all the Savara's financials.

Savara share price movements

  • Today's Low: $3.09
    Today's High: $3.27

    Day's Volatility :5.45%

  • 52 Weeks Low: $2.82
    52 Weeks High: $5.70

    52 Weeks Volatility :50.61%

Savara Returns

PeriodSavara IncIndex (Russel 2000)
3 Months
-24.53%
0.0%
6 Months
-16.01%
0.0%
1 Year
-33.33%
0.0%
3 Years
111.92%
-21.1%

Savara Key Statistics

in dollars & INR

Previous Close
$3.25
Open
$3.23
Today's High
$3.27
Today's Low
$3.0918
Market Capitalization
$549.2M
Today's Volume
$895.4K
52 Week High
$5.7
52 Week Low
$2.815
Revenue TTM
$1000.0
EBITDA
$-88.7M
Earnings Per Share (EPS)
$-0.43
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-47.96%

How to invest in Savara from India?

It is very easy for Indian residents to invest directly in Savara from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Savara stock in both Indian Rupees (INR) and US Dollars (USD). Search for Savara or SVRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Savara or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Savara shares which would translate to 0.266 fractional shares of Savara as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Savara, in just a few clicks!

Returns in Savara for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Savara investment value today

Current value as on today

₹68,905

Returns

₹31,095

(-31.09%)

Returns from Savara Stock

₹33,333 (-33.33%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Savara

-39%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Savara on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -39% less investors are searching Savara in the last 30 days versus the previous period.

Global Institutional Holdings in Savara

  • NEA Management Company, LLC

    14.26%

  • Bain Capital Life Sciences Investors, LLC

    8.49%

  • TCG Crossover Management, LLC

    7.20%

  • Wellington Management Company LLP

    5.03%

  • Vestal Point Capital LP

    4.71%

  • BlackRock Inc

    4.68%

Analyst Recommendation on Savara

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Savara(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Savara

What analysts predicted

Upside of 198.83%

Current:

$3.20

Target:

$9.56

Insights on Savara

  • Price Movement

    In the last 7 days, SVRA stock has moved down by -0.9%
  • SVRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 60.3%

Savara Technicals Summary

Sell

Neutral

Buy

Savara is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Savara Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Savara Inc
-7.51%
-16.01%
-33.33%
111.92%
111.92%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Savara Inc
NA
NA
0.0
-0.46
-0.48
-0.26
NA
1.17
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Savara Inc
Buy
$549.2M
111.92%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Savara

savara pharmaceuticals is an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions. the company’s lead product, aerovanc is the first dry powder inhaled antibiotic for the treatment of methicillin-resistant staphylococcus aureus (mrsa) infection in patients with cystic fibrosis (cf). for more information, please see savara’s website at www.savarapharma.com or www.aerovanc.com
Organization
Savara
Employees
37
CEO
Mr. Matthew Pauls J.D., M.B.A.
Industry
Health Technology

Management People of Savara

NameTitle
Mr. Matthew Pauls J.D., M.B.A.
Chairman & CEO
Mr. David L. Lowrance CPA
CFO, Chief Administrative Officer & Secretary
Mr. Robert Lutz M.B.A.
Chief Operating Officer
Ms. Kate McCabe J.D.
Senior VP & General Counsel
Ms. Anne Erickson
Chief Business Officer
Brian Maurer
Head of Clinical Operations
Mr. Charles LaPree
Senior Vice President of Global Regulatory Affairs & Quality Assurance
Dr. Peter Clarke Ph.D.
Executive Vice President of Global Technical Operations
Dr. Raymond Dennis Pratt FACP, M.D.
Chief Medical Officer
Mr. Scott L. Wilhoit
Executive Vice President of Global Commercial

Important FAQs about investing in Savara from India :

What is Savara share price today?

Savara share price today stands at $3.20, Open: $3.23 ; Previous Close: $3.25 ; High: $3.27 ; Low: $3.09 ; 52 Week High: $5.70 ; 52 Week Low: $2.82. The stock opens at $3.23, after a previous close of $3.25. The stock reached a daily high of $3.27 and a low of $3.09, with a 52-week high of $5.70 and a 52-week low of $2.82.

Can Indians buy Savara shares?

Yes, Indians can invest in the Savara (SVRA) from India.

With INDmoney, you can buy Savara at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Savara at zero transaction cost.

How can I buy Savara shares from India?

It is very easy to buy Savara from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Savara be purchased?

Yes, you can buy fractional shares of Savara with INDmoney app.

What are the documents required to start investing in Savara stocks?

To start investing in Savara, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Savara

Today’s highest price of Savara (SVRA) is $3.27.

Today’s lowest price of Savara (SVRA) is $3.09.

What is today's market capitalisation of Savara

Today's market capitalisation of Savara SVRA is 549.2M

What is the 52 Week High and Low Range of Savara

  • 52 Week High

    $5.70

  • 52 Week Low

    $2.82

What are the historical returns of Savara?

  • 1 Month Returns

    -7.51%

  • 3 Months Returns

    -16.01%

  • 1 Year Returns

    -33.33%

  • 5 Years Returns

    111.92%

Who is the Chief Executive Officer (CEO) of Savara

Mr. Matthew Pauls J.D., M.B.A. is the current Chief Executive Officer (CEO) of Savara.